1040.2000 -3.90 (-0.37%)
NSE Sep 08, 2025 15:31 PM
Volume: 415.8K
 

BOB Capital Markets Ltd.
Q1 revenue of Rs 62bn came in 5% above consensus as US business outperformed; however, EBITDA margin slid 570bps YoY to 15.5%
Aurobindo Pharma Ltd. is trading below all available SMAs
More from Aurobindo Pharma Ltd.
Recommended